Impact of COVID-19 on the CDK 7 Inhibitors Market
While the COVID-19 pandemic temporarily hindered the progress of CDK 7 inhibitors, it has also highlighted their potential role in revolutionizing cancer treatment. As clinical trials resume and new data emerges, CDK 7 inhibitors are poised to become an important tool in the oncology arsen
